Dog Aging Project Update Prof Matt Kaeberlein R Longevity This video is a great talk from dr. matt kaeberlein at raadfest 2025, which took place a few weeks ago in las vegas. the first part of matt’s presentation is a great overview of the dog aging project and why companion animals (dogs) are great organisms to study the biology of aging. Our discoveries about healthy aging in our canine companions will translate into medical advances for people too. we’re working toward a future where dogs, and their humans, can live longer and stay healthier—together!.
Dr Matt Kaeberlein On Wormbot And The Dog Aging Project R Longevity Kaeberlein: the dog aging project is a scientifically rigorous approach to understand the biology of aging in companion dogs and to discover ways to help them live longer, healthier lives. The test of rapamycin in aging dogs (triad) is a notable ongoing study—a parallel group, double masked, randomized, placebo controlled, multicenter trial—that aims to test the ability of rapamycin to prolong lifespan and improve healthspan metrics in healthy, middle aged dogs (8). The dog aging project is making strides in understanding canine longevity, with over 50,000 dogs enrolled in the study since its inception in 2018. the project, co directed by matt kaeberlein, aims to explore the biology of aging in dogs and identify ways to extend their lifespan. Dogs are considered man’s best friends by many. thanks to advances in longevity research, their life expectancy can be extended by up to 25 percent. experts at petmoretime explain what lies behind this development—and why even humans stand to benefit from it.
Dr Matt Kaeberlein The Dog Aging Project Lifeboat News The Blog The dog aging project is making strides in understanding canine longevity, with over 50,000 dogs enrolled in the study since its inception in 2018. the project, co directed by matt kaeberlein, aims to explore the biology of aging in dogs and identify ways to extend their lifespan. Dogs are considered man’s best friends by many. thanks to advances in longevity research, their life expectancy can be extended by up to 25 percent. experts at petmoretime explain what lies behind this development—and why even humans stand to benefit from it. They explore the dog aging project, a large scale study testing rapamycin in companion dogs, as well as human evidence related to vaccine response, alzheimer’s risk, and post viral conditions. The dog aging project, led by professor matt kaeberlein, studies factors influencing health outcomes in aging dogs. over 45,000 dogs in the u.s. are involved, with a specific trial on 580 dogs to examine the effects of rapamycin on lifespan. Matt kaeberlein: update on the dog aging project: companion animals as a catalyst toward human longevity therapeutics. 13. mac davis: unlocking the body’s longevity genes: klotho, follistatin, and beyond (intro). In our latest ticktective interview, dana parish delves into the intricacies of this groundbreaking project with dr. kaeberlein and learns what animals, particularly dogs, can teach us about aging better.
Comments are closed.